CORONA Remedies Ltd. benchmarking: Perfomance to industry peers

Financial

	CORONA Remedies	Abbott India	Alkem Laboratories
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	1.41 %	0.02 %	3.3 %
Financials
5 yr Average ROE	21.43 %	30.11 %	17.38 %
5yr average Equity Multiplier	1.71	1.43	1.39
5yr Average Asset Turnover Ratio	1.22	1.14	0.86
5yr Avg Net Profit Margin	10.34 %	18.53 %	14.54 %
Price to Book	13.59	15.16	4.98
P/E	55.14	40.3	28.18
5yr Avg Cash Conversion Cycle	-132.09 Days	-46.68 Days	-61.46 Days
Inventory Days	37.61 Days	45.22 Days	56.11 Days
Days Receivable	32.7 Days	19.34 Days	44.62 Days
Days Payable	176.7 Days	109.21 Days	122.42 Days
5yr Average Interest Coverage Ratio	18.64	97.37	24.48
5yr Avg ROCE	25.84 %	38.77 %	22.76 %
5yr Avg Operating Profit Margin	16.6 %	23.42 %	18.44 %
5 yr average Debt to Equity	0.13	0.0	0.18
5yr CAGR Net Profit	11.96 %	95.4 %	6.44 %
5yr Average Return on Assets	12.62 %	21.03 %	12.47 %
Shareholdings
Promoter Holding	69.0 %	74.99 %	51.2 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	-5.96 %
Change in Mutual Fund Holding (3 Yrs)	0.0	2.11 %	7.52 %

	CORONA Remedies	Abbott India	Alkem Laboratories
Location Wise Break-Up	Location Wise Break-Up India 96.34 Outside India 3.66 Rest of the World 0 USA 0	Location Wise Break-Up India 98.81 Outside India 0 Rest of the World 1.19 USA 0	Location Wise Break-Up India 69.13 Outside India 0 Rest of the World 0 USA 29.72 Others 1.15
Acute vs Chronic	Acute vs Chronic Chronic and subchronic 70.1 Acute 29.9 Sub-chronic 0 Chronic 0	Acute vs Chronic Chronic 46.0 Acute 27.0 Chronic and subchronic 0 Sub-chronic 27.0	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up Women’s Healthcare 28.1 Cardio-diabeto 25.09 Pain Management 11.94 Urology 3.0 Others 31.87	-	-
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise India 98.49 Others 1.51	-	-